◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

MediPal Holdings Corporation (7459)

Name: MediPal Holdings Corporation（7459）— 财务报表历史
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

来自官方财务报表的收入、利润与现金流历史。

Healthcare · 华尔街（美国） · 最近更新： 2026-10-02

MediPal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. The company engages in the manufacture and supply of medical drugs, medical devices, medical supplies, clinical test reagents, and medical equipment and materials; non-life insurance agency business; outsourcing of medical office administration services; research and development of preventive medicine and cutting-edge medical technologies; and construction of a medical materials database.

关键数据

市值: JPY 598 billion
收入（截至 2026-03-31 财年）: JPY 3.82T
净利润: JPY 42.5B
毛利率: 6.8%
净利率: 1.1%

查看交互式图表与完整报表 → 估值模型 (DCF) →

年度利润表

利润表	2026-03-31	2025-03-31	2024-03-31	2023-03-31
总收入	JPY 3.82T	JPY 3.67T	JPY 3.56T	JPY 3.36T
毛利	JPY 261.0B	JPY 255.8B	JPY 246.7B	JPY 224.3B
营业利润（EBIT）	JPY 53.2B	JPY 55.6B	JPY 47.3B	JPY 49.0B
净利	JPY 42.5B	JPY 40.3B	JPY 41.5B	JPY 38.8B

来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。

资产负债表、现金流、季度数据与完整财务比率见 7459 交互式查看器。 /companies/us/7459

类似公司

本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。

English version →全部股票

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.